Evidence map›Paper›PMID 34862628›Full record

ArticleJournal of medical virology2022

Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea.

Ae Kyung Park, Jee Eun Rhee, Il-Hwan Kim, Heui Man Kim, Hyeokjin Lee, Jeong-Ah Kim, Chae Young Lee, Nam-Joo Lee, SangHee Woo, Jaehee Lee and 10 more

Abstract read
In one paragraph

Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ae Kyung ParkDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Jee Eun RheeDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Il-Hwan KimDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Heui Man KimDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Hyeokjin LeeDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Jeong-Ah KimDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Chae Young LeeDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Nam-Joo LeeDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
SangHee WooDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Jaehee LeeDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Jin Sun NoDivision of High-Risk Pathogens, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Gi-Eun RhieDivision of High-Risk Pathogens, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Seong Jin WangEpidemiological Investigation Team, Epidemiological Investigation and Analysis Task Force, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Sang-Eun LeeEpidemiological Investigation Team, Epidemiological Investigation and Analysis Task Force, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Young Joon ParkEpidemiological Investigation Team, Epidemiological Investigation and Analysis Task Force, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Gemma ParkCase and Guideline Management Team, Infection Prevention Support Team, Central Disease Control Headquarters, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Jung Yeon KimCase and Guideline Management Team, Infection Prevention Support Team, Central Disease Control Headquarters, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Jin GwackCase and Guideline Management Team, Infection Prevention Support Team, Central Disease Control Headquarters, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Cheon-Kwon YooBureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Chungcheongbuk-do, Republic of Korea.
Eun-Jin KimDivision of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea.

Funding

Korea Disease Control and Prevention Agency
6 · The paper itself

Abstract

As the coronavirus disease 2019 (COVID-19) pandemic continues, reinfection is likely to become increasingly common. However, confirming COVID-19 reinfection is difficult because it requires whole-genome sequencing of both infections to identify the degrees of genetic differences. Since the first reported case of reinfection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Republic of Korea in April 2020, four additional cases were classified as suspected reinfection cases. We performed whole-genome sequencing of viral RNA extracted from swabs obtained at the initial infection and reinfection stages of these four suspected cases. The interval between initial infection and reinfection of all four suspected cases was more than 3 months. All four patients were young (10-29 years), and they displayed mild symptoms or were asymptomatic during the initial infection and reinfection episodes. The analysis of genome sequences combined with the epidemiological results revealed that only two of the four cases were confirmed as reinfection, and both were reinfected with the Epsilon variant. Due to the prolonged COVID-19 pandemic, the possibility of reinfections with SARS-CoV-2 variants is increasing, as reported in our study. Therefore, continuous monitoring of cases is necessary.

Indexed as

AdolescentAdultCOVID-19FemaleGenome, ViralGenomicsHumansMaleMutationPhylogenyReinfectionRepublic of KoreaRNA, ViralSARS-CoV-2RNA, ViralEpsilon variantreinfectionRepublic of KoreaSARS-CoV-2whole genome sequencing

Identifiers

PMID34862628
PMCPMC9015470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.